Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical piroxicam nanoniosome emulgel for joint pain in OA or RA
IRCT20180526039839N1Phase 3Completed
- Sponsor
- Daroo Sazan Sorena Exir
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of piroxicam in osteoarthritis (OA) and rheumatoid arthritis (RA), sponsored by Daroo Sazan Sorena Exir. Started Feb 2024; status: completed.
02
Drugs
piroxicam
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT20180526039839N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180526039839N1.